Dental RestorationNCT01529606
Cold Plasma for Dental Restoration and Caries Prevention
A study testing Composite restoration and tooth cleaning and Plasma treatment in people with Dental Restoration and Caries, run by Nanova, Inc at 1 site in United States.
Trial summary
The main objective of this entire research project is to develop a miniature atmospheric cold plasma brush (m-ACPB) for dental clinical applications. The objective of the clinical trial portion of the study is to compare the longevity and durability of dental composite restorations created using the plasma brush, to… Read more about this study
- Who is it for?
- Ages 18 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Dental Restoration, Caries
- What is being tested?
- Composite restoration and tooth cleaning and Plasma treatment
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 102 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2012to Jun 2014
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- subject must be Caucasian or Africa American, 18-35 years old, have written, completed, informed consent forms;
- be generally healthy;
- be able to participate in the study;
- have no diagnosed periodontitis and pericoronitis;
- have no active mucosal diseases such as aphthous ulcers and herpetic stomatitis.
- They must also agree to follow study instructions.
- The patients must meet the following specific entry criteria:
- 1-5 untreated caries and at least one class II caries.
Who cannot join
- each subject must have no diagnosed diabetes mellitus or any other endocrine diseases;
- no diagnosed cardiovascular diseases;
- no diagnosed immune-compromised diseases, such as HIV and AIDS;
- no other serious systemic diseases, such as cancer;
- no antibiotic therapy in the past 6 months;
- no use of non-steroidal anti-inflammatory drugs (NSAIDS) in the past 3 months; and
- no reported use of illicit drugs.
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Tennessee Health Science
Memphis, Tennessee, 38163
About this study
Official title: Development of a Miniature Plasma Brush for Dental Clinical Applications
The main objective of this entire research project is to develop a miniature atmospheric cold plasma brush (m-ACPB) for dental clinical applications. The objective of the clinical trial portion of the study is to compare the longevity and durability of dental composite restorations created using the plasma brush, to that of the standard care in dentistry for treating dental cavities, and effects on caries prevention.
Read the detailed description
The study will be a randomized controlled trial (RCT) and be approved by the institute review board of the University of Tennessee Health Science Center. The study subjects will be composed of young adults 18-35 years old in order to control effects of age on caries. Also the subjects must be Caucasian or Africa American. Young adult patients will be recruited from the UTHSC dental clinics.The baseline visit include a dental exam by one of the investigators, standard preventive dental care (e.g cleaning, application of fluoride varnish), anthropometric measurements, oral health interview survey. 100 patients who meet all inclusion and exclusion criteria will be recruited after they sign an informed consent form. These patients will be randomly assigned to 1 of 2 study groups. Randomization assignment will be stratified by age and number of teeth with caries. Two study groups will be: 1.) plasma treatment group and 2) standard treatment group. For patients in standard treatment group, they will receive composite resin restoration for all decayed teeth and standard preventive treatment (cleaning and fluoride varnish application) at baseline. For patients in plasma treatment group, they will receive plasma treatment after cavity preparation, composite resin restoration, standard preventive treatment followed by plasma treatment for non-carious teeth. Standard preventive treatment and plasma treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction. Only one composite commercially available will be used during the study.
- Conditions
- Dental Restoration, Caries
- Being tested
- Composite restoration and tooth cleaning, Plasma treatment
- Keywords
- dental restoration, dental caries, tooth cavity
- Medical subject headings
- Dental Caries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Composite restoration and tooth cleaningOther
Also called Standard composite filling and preventive treatment
Standard preventive treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction.
Plasma treatmentProcedure or surgery
Also called Plasma treatment and standard preventive treatment
plasma treatment after preparation and for caries prevention
| Study group | Role | What they receive |
|---|---|---|
| Standard care | Active comparator | Fifty patients will be recruited into standard treatment group and they will receive composite resin restoration for all decayed teeth and standard preventive treatment (cleaning and fluoride varnish application) at baseline. Receives: Other: Composite restoration and tooth cleaning |
| Plasma treatment | Experimental | Fifty patients will be recruited into plasma treatment group and they will receive plasma treatment after cavity preparation, composite resin restoration, standard preventive treatment followed by plasma treatment for non-carious teeth. Receives: Procedure: Plasma treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Decayed, Missing and Filling Teeth (DMFT)
Number of decayed, missing and filling teeth (DMFT) during 12 months
Measured: 12 months
Decayed and Filling Surfaces
Number of decayed and filling surfaces
Measured: 12 months
Restoration Failure Rate
Composite restoration evaluation for fracture or loss of filling partially or completely, with or without recurrent caries.
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2012 (estimated)
- Study startSep 2012
- Primary completionJun 2014
- Study completionJun 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Dental RestorationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 102 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nanova, Inc
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- National Institute of Dental and Craniofacial Research (NIDCR)
- Responsible party
- Principal investigator, Liang Hong, University of Tennessee
- Investigators
- Liang Hong, DDS, Ph.D, Principal investigator, The University of Tennessee Health Science Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01529606
- Sponsor's protocol ID
- 5R44DE019041
- Other IDs
- 5R44DE019041
- Status last verified
- Apr 2020
- First submitted
- 3 Feb 2012
- Last updated
- 16 Apr 2020
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 16 Apr 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development of a Miniature Plasma Brush for Dental Clinical Applications
- ClinicalTrials.gov ID
- NCT01529606
- Acronym / sponsor ID
- 5R44DE019041
- Conditions
- Dental Restoration, Caries
- Keywords
- dental restoration, dental caries, tooth cavity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 102 participants (actual)
- Lead sponsor
- Nanova, IncIndustry (pharma, biotech, devices)
- Collaborators
- National Institute of Dental and Craniofacial Research (NIDCR)
- Study start
- Sep 2012
- Primary completion
- Jun 2014 (actual)
- Study completion
- Jun 2014 (actual)
- First posted
- 9 Feb 2012 (estimated)
- Results
- Posted 16 Apr 2020
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main objective of this entire research project is to develop a miniature atmospheric cold plasma brush (m-ACPB) for dental clinical applications. The objective of the clinical trial portion of the study is to compare the longevity and durability of dental composite restorations created using the plasma brush, to that of the standard care in dentistry for treating dental cavities, and effects on caries prevention.
Detailed description
The study will be a randomized controlled trial (RCT) and be approved by the institute review board of the University of Tennessee Health Science Center. The study subjects will be composed of young adults 18-35 years old in order to control effects of age on caries. Also the subjects must be Caucasian or Africa American. Young adult patients will be recruited from the UTHSC dental clinics.The baseline visit include a dental exam by one of the investigators, standard preventive dental care (e.g cleaning, application of fluoride varnish), anthropometric measurements, oral health interview survey. 100 patients who meet all inclusion and exclusion criteria will be recruited after they sign an informed consent form. These patients will be randomly assigned to 1 of 2 study groups. Randomization assignment will be stratified by age and number of teeth with caries. Two study groups will be: 1.) plasma treatment group and 2) standard treatment group. For patients in standard treatment group, they will receive composite resin restoration for all decayed teeth and standard preventive treatment (cleaning and fluoride varnish application) at baseline. For patients in plasma treatment group, they will receive plasma treatment after cavity preparation, composite resin restoration, standard preventive treatment followed by plasma treatment for non-carious teeth. Standard preventive treatment and plasma treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction. Only one composite commercially available will be used during the study.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Standard care | Active comparator | Other: Composite restoration and tooth cleaningFifty patients will be recruited into standard treatment group and they will receive composite resin restoration for all decayed teeth and standard preventive treatment (cleaning and fluoride varnish application) at baseline. |
| Plasma treatment | Experimental | Procedure: Plasma treatmentFifty patients will be recruited into plasma treatment group and they will receive plasma treatment after cavity preparation, composite resin restoration, standard preventive treatment followed by plasma treatment for non-carious teeth. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- subject must be Caucasian or Africa American, 18-35 years old, have written, completed, informed consent forms;
- be generally healthy;
- be able to participate in the study;
- have no diagnosed periodontitis and pericoronitis;
- have no active mucosal diseases such as aphthous ulcers and herpetic stomatitis.
Key exclusion criteria (7 listed)
- each subject must have no diagnosed diabetes mellitus or any other endocrine diseases;
- no diagnosed cardiovascular diseases;
- no diagnosed immune-compromised diseases, such as HIV and AIDS;
- no other serious systemic diseases, such as cancer;
- no antibiotic therapy in the past 6 months;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Composite restoration and tooth cleaningAlso: Standard composite filling and preventive treatmentStandard preventive treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction. | Other | Standard care |
| Plasma treatmentAlso: Plasma treatment and standard preventive treatmentplasma treatment after preparation and for caries prevention | Procedure or surgery | Plasma treatment |
Primary outcome
Number of Decayed, Missing and Filling Teeth (DMFT)
Time frame: 12 months
Number of decayed, missing and filling teeth (DMFT) during 12 months
Decayed and Filling Surfaces
Time frame: 12 months
Number of decayed and filling surfaces
Restoration Failure Rate
Time frame: 12 months
Composite restoration evaluation for fracture or loss of filling partially or completely, with or without recurrent caries.
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Apr 2020.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Dental Restoration
Not yet recruiting
Clinical and 3D Evaluation of Injectable Versus Conventional Composite in Class V Restorations
Class V Dental Restorations
Not yet recruiting
The Effect of Decoupling With Time Technique on the Clinical Performance of Proximal Posterior Composite Restorations
Dental Restoration Failure, Postoperative Hypersensitivity
Active, not recruiting
Clinical Evaluation of a New Dual-cure Universal Adhesive
Class I Dental Restorations, Class II Dental Restorations
Active, not recruiting
A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive
Bracket Bonding, Orthodontic Treatment
Not yet recruiting
Clinical Performance of Glass Hybrid and Alkasite Restorative Systems in MIH-Affected Permanent First Molars
Molar-Incisor Hypomineralization (MIH)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Liang Hong, DDS, Ph.D principal investigator
The University of Tennessee Health Science Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Composite restoration and tooth cleaning and Plasma treatment in people with Dental Restoration and Caries, run by Nanova, Inc at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 16 Apr 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of Decayed, Missing and Filling Teeth (DMFT) (time frame: 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2020.